Pfizer Ltd. on Monday reported a 61.1 percent rise in net profit for the first quarter of this fiscal year, beating analysts’ estimates.
According to its stock exchange filing, the biopharmaceutical company reported a net profit of Rs 151 crore for the quarter ended June, compared to Rs 94 crore in the same quarter last fiscal. This compares to the estimate of Rs 139.5 crore by analysts tracked by Bloomberg.
Revenue rose 5.9 percent from a year earlier for the three months ended June to 563 million rupees. Analysts had expected revenue of 536.7 million rupees.
Operating profit, or earnings before interest, taxes, depreciation and amortisation, rose 60.3% year-on-year to Rs 177 crore. Ebitda margin widened to 31.5% from 20.8% in the same period last year. Analysts’ estimates for Ebitda and Ebitda margin tracked by Bloomberg were Rs 164.7 crore and 30.70%, respectively.
The company’s shares closed 2.49 per cent higher at Rs 5,374 per share, compared to the NSE Nifty 50’s 0.02 per cent gain.